サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1449250

エソメプラゾール市場、シェア、市場規模、動向、産業分析レポート：製品別、用途別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
エソメプラゾール市場、シェア、市場規模、動向、産業分析レポート：製品別、用途別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年02月24日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、エソメプラゾールの世界市場規模は2032年までに28億7,207万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

エソメプラゾールは、胃潰瘍、胃食道逆流症、ゾリンジャー・エリソン症候群などの世界の有病率に起因する世界のヘルスケア空間で重要性を増しています。胃酸を低下させるエソメプラゾールの高い有効性は、今後数年間のエソメプラゾール市場の拡大に拍車をかけています。

エソメプラゾールは治療プロセスで広く利用されているため、人々の胃腸障害の増加がエソメプラゾールの大きな需要を示しています。2023年の調査によると、COVID-19に感染している人は、その年に胃食道逆流症を発症するリスクが高く（39％）、COVID-19ウイルスに感染していない人と一致して感染が続く。この調査は、調査期間中の市場の新たな成長機会を示しています。

マーケットプレースでエソメプラゾールの生産に参入する市場プレイヤーの出現は、今後数年間のエソメプラゾール市場規模を高める可能性が高いです。例えば、2023年、Granules India Limitedは、米国食品医薬品局（US FDA）から、USP、20mg、40mgの強度のエソメプラゾールマグネシウム遅延放出カプセルの略式新薬申請（ANDA）の承認を受けた。これらの取り組みにより、同薬の市場供給が強化されることが期待されます。

製薬会社は、胃潰瘍や十二指腸潰瘍を含む数多くの未解決の健康問題に対する効果的な薬剤を革新するため、研究開発活動を強化しています。例えば、2023年4月、アクムス薬品は、ピロリ菌感染と十二指腸潰瘍の治療のための新しいコンビキットを発表しました。こうした発展は、世界中で新たなエソメプラゾール市場機会を創出する可能性が高いです。

インターネットへのアクセス機会が増えたことで、世界における情報の非対称性が低下し、医薬品に関する知識の向上が促進されました。人口の胃に関連する問題の増加は、予測期間中、マーケットプレースで市販薬を通じてエソメプラゾール医薬品の大きな需要を促進すると思われます。

より多くの企業が医薬品、特にエソメプラゾールの生産に参入しており、世界市場の拡大を牽引しています。例えば、2023年10月、Marksans社はエソメプラゾールマグネシウムカプセルの製造承認を取得しました。

エソメプラゾール市場レポートハイライト

カプセル剤は錠剤よりも作用が優れているため、今後数年間で最も高い成長が見込まれる

胃食道逆流症市場は、胃酸逆流症例の増加により最大の市場シェアを占める

病院・調剤薬局セグメントは、患者アクセスの増加により、より大きな収益シェアを占めると予測されます。

APACは、高齢者人口の存在に起因して、予測期間中に最速の成長を記録すると予測されています。

目次

イントロダクション

  • レポートの説明
    • 研究の目的
    • 市場範囲
    • 仮定
  • 利害関係者

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のエソメプラゾール市場に関する洞察

  • エソメプラゾール市場- 流通チャネルのスナップショット
  • エソメプラゾール市場力学
    • 促進要因と機会
      • 胃腸炎症例の増加が市場を牽引
      • 食生活の変化と肥満の増加が市場を牽引
    • 抑制要因と課題
      • エソメプラゾールに関連する副作用は市場の成長を妨げる可能性が高い
  • PESTEL分析
  • エソメプラゾール市場流通チャネルの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のエソメプラゾール市場、用途別

  • 主な調査結果
  • イントロダクション
  • 胃食道逆流症
  • びらん性食道炎
  • 消化性潰瘍
  • 十二指腸潰瘍
  • ゾリンジャー・エリソン症候群
  • その他

第6章 世界のエソメプラゾール市場、製品別

  • 主な調査結果
  • イントロダクション
  • カプセル
  • タブレット
  • 注射
  • その他

第7章 世界のエソメプラゾール市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院と薬局
  • オンライン薬局
  • OTC

第8章 世界のエソメプラゾール市場、地域別

  • 主な調査結果
  • イントロダクション
    • エソメプラゾール市場評価、地域別、2019-2032年
  • エソメプラゾール市場-北米
    • 北米：エソメプラゾール市場、用途別、2019-2032年
    • 北米：エソメプラゾール市場、流通チャネル別、2019-2032年
    • 北米：エソメプラゾール市場、製品別、2019-2032年
    • エソメプラゾール市場-米国
    • エソメプラゾール市場- カナダ
  • エソメプラゾール市場- 欧州
    • 欧州：エソメプラゾール市場、用途別、2019-2032年
    • 欧州：エソメプラゾール市場、流通チャネル別、2019-2032
    • 欧州：エソメプラゾール市場、製品別、2019-2032年
    • エソメプラゾール市場- 英国
    • エソメプラゾール市場- フランス
    • エソメプラゾール市場- ドイツ
    • エソメプラゾール市場- イタリア
    • エソメプラゾール市場- スペイン
    • エソメプラゾール市場- オランダ
    • エソメプラゾール市場- ロシア
  • エソメプラゾール市場- アジア太平洋
    • アジア太平洋：エソメプラゾール市場、用途別、2019～2032年
    • アジア太平洋：エソメプラゾール市場、流通チャネル別、2019-2032
    • アジア太平洋：エソメプラゾール市場、製品別、2019-2032年
    • エソメプラゾール市場- 中国
    • エソメプラゾール市場- インド
    • エソメプラゾール市場- マレーシア
    • エソメプラゾール市場- 日本
    • エソメプラゾール市場- インドネシア
    • エソメプラゾール市場- 韓国
  • エソメプラゾール市場-中東およびアフリカ
    • 中東およびアフリカ：エソメプラゾール市場、用途別、2019-2032年
    • 中東およびアフリカ：エソメプラゾール市場、流通チャネル別、2019-2032
    • 中東およびアフリカ：エソメプラゾール市場、製品別、2019-2032年
    • エソメプラゾール市場- サウジアラビア
    • エソメプラゾール市場- アラブ首長国連邦
    • エソメプラゾール市場- イスラエル
    • エソメプラゾール市場- 南アフリカ
  • エソメプラゾール市場-ラテンアメリカ
    • ラテンアメリカ：エソメプラゾール市場、用途別、2019-2032年
    • ラテンアメリカ：エソメプラゾール市場、流通チャネル別、2019-2032
    • ラテンアメリカ：エソメプラゾール市場、製品別、2019-2032年
    • エソメプラゾール市場- メキシコ
    • エソメプラゾール市場- ブラジル
    • エソメプラゾール市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Actavis（US）
  • AstraZeneca AB（UK）
  • Blaskov（Columbia）
  • CQ Lummy（China）
  • KernPharm（Spain）
  • Mepha（India）
  • Mylan（US）
  • Sandoz（Switzerland）
  • Sanofi（France）
  • Saval Pharmaceutical（Chile）
  • Stada Arzneimittel AG（Germany）
  • Teva Pharmaceuticals（Israel）
図表

List of Tables

  • Table 1 Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 3 Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 6 North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 7 North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 9 U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 10 U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 12 Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 13 Canada: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 15 Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 16 Europe: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 18 UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 19 UK: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 21 France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 22 France: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 25 Germany: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 27 Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 28 Italy: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 30 Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 31 Spain: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 33 Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 34 Netherlands: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 36 Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 37 Russia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 42 China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 43 China: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 45 India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 46 India: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 48 Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 49 Malaysia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 51 Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 52 Japan: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 54 Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 55 Indonesia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 57 South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 58 South Korea: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 66 UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 67 UAE: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 69 Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 70 Israel: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 72 South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 73 South Africa: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 75 Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 76 Latin America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 78 Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 79 Mexico: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 81 Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 82 Brazil: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 84 Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 85 Argentina: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Esomeprazole Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Esomeprazole Market, by Product, 2022 & 2032 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Esomeprazole Market, by Application, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Esomeprazole Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Esomeprazole Market
目次
Product Code: PM4436

The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report "Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.

The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.

The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.

Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.

The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.

More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.

Esomeprazole Market Report Highlights

Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.

Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.

Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.

APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.

The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.

Polaris Market Research has segmented the esomeprazole market report based on product, application, distribution channel and region:

Esomeprazole, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Capsules
  • Tablets
  • Injections
  • Others

Esomeprazole, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Gastroesophageal reflux disease
  • Erosive Esophagitis
  • Peptic Ulcers
  • Duodenal Ulcers
  • Zollinger-Ellison Syndrome
  • Others

Esomeprazole, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals & Clinical Pharmacies
  • Online Pharmacies
  • OTC

Esomeprazole, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Esomeprazole Market Insights

  • 4.1. Esomeprazole Market - Distribution Channel Snapshot
  • 4.2. Esomeprazole Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising gastroenteritis cases drives the market
      • 4.2.1.2. The changing eating patterns and rising obesity drives the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The side-effects associated with esomeprazole are likely to hinder market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Esomeprazole Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Esomeprazole Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • 5.3. Gastroesophageal reflux disease
    • 5.3.1. Global Esomeprazole Market, by Gastroesophageal reflux disease, by Region, 2019-2032 (USD Million)
  • 5.4. Erosive Esophagitis
    • 5.4.1. Global Esomeprazole Market, by Erosive Esophagitis, by Region, 2019-2032 (USD Million)
  • 5.5. Peptic Ulcers
    • 5.5.1. Global Esomeprazole Market, by Peptic Ulcers, by Region, 2019-2032 (USD Million)
  • 5.6. Duodenal Ulcers
    • 5.6.1. Global Esomeprazole Market, by Duodenal Ulcers, by Region, 2019-2032 (USD Million)
  • 5.7. Zollinger-Ellison Syndrome
    • 5.7.1. Global Esomeprazole Market, by Zollinger-Ellison Syndrome, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Esomeprazole Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 6.3. Capsules
    • 6.3.1. Global Esomeprazole Market, by Capsules, by Region, 2019-2032 (USD Million)
  • 6.4. Tablets
    • 6.4.1. Global Esomeprazole Market, by Tablets, by Region, 2019-2032 (USD Million)
  • 6.5. Injections
    • 6.5.1. Global Esomeprazole Market, by Injections, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Esomeprazole Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinical Pharmacies
    • 7.3.1. Global Esomeprazole Market, by Hospitals & Clinical Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Online Pharmacies
    • 7.4.1. Global Esomeprazole Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. OTC
    • 7.5.1. Global Esomeprazole Market, by OTC, By Region, 2019-2032 (USD Million)

8. Global Esomeprazole Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Esomeprazole Market - North America
    • 8.3.1. North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.3.2. North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.3.4. Esomeprazole Market - U.S.
      • 8.3.4.1. U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.3.5. Esomeprazole Market - Canada
      • 8.3.5.1. Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.4. Esomeprazole Market - Europe
    • 8.4.1. Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.4. Esomeprazole Market - UK
      • 8.4.4.1. UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.5. Esomeprazole Market - France
      • 8.4.5.1. France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.6. Esomeprazole Market - Germany
      • 8.4.6.1. Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.7. Esomeprazole Market - Italy
      • 8.4.7.1. Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.8. Esomeprazole Market - Spain
      • 8.4.8.1. Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.9. Esomeprazole Market - Netherlands
      • 8.4.9.1. Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.10. Esomeprazole Market - Russia
      • 8.4.10.1. Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.5. Esomeprazole Market - Asia Pacific
    • 8.5.1. Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.4. Esomeprazole Market - China
      • 8.5.4.1. China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.5. Esomeprazole Market - India
      • 8.5.5.1. India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.6. Esomeprazole Market - Malaysia
      • 8.5.6.1. Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.7. Esomeprazole Market - Japan
      • 8.5.7.1. Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.8. Esomeprazole Market - Indonesia
      • 8.5.8.1. Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.9. Esomeprazole Market - South Korea
      • 8.5.9.1. South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.6. Esomeprazole Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.4. Esomeprazole Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.5. Esomeprazole Market - UAE
      • 8.6.5.1. UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.6. Esomeprazole Market - Israel
      • 8.6.6.1. Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.7. Esomeprazole Market - South Africa
      • 8.6.7.1. South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.7. Esomeprazole Market - Latin America
    • 8.7.1. Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.4. Esomeprazole Market - Mexico
      • 8.7.4.1. Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.5. Esomeprazole Market - Brazil
      • 8.7.5.1. Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.6. Esomeprazole Market - Argentina
      • 8.7.6.1. Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Actavis (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca AB (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Blaskov (Columbia)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. CQ Lummy (China)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. KernPharm (Spain)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mepha (India)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sandoz (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi (France)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Saval Pharmaceutical (Chile)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Stada Arzneimittel AG (Germany)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Teva Pharmaceuticals (Israel)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development